Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia.

Literature DB >> 29899367

Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia.

Thomas Ernst¹, Melinda Busch², Jenny Rinke², Jana Ernst³, Claudia Haferlach⁴, James F Beck³, Andreas Hochhaus², Bernd Gruhn³.

Abstract

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2018 PMID： 29899367 DOI： 10.1038/s41375-018-0157-2

Source DB: PubMed Journal: Leukemia ISSN： 0887-6924 Impact factor: 11.528

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

Review 1. Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia.

Authors: Susan Branford; Dennis Dong Hwan Kim; Jane F Apperley; Christopher A Eide; Satu Mustjoki; S Tiong Ong; Georgios Nteliopoulos; Thomas Ernst; Charles Chuah; Carlo Gambacorti-Passerini; Michael J Mauro; Brian J Druker; Dong-Wook Kim; Francois-Xavier Mahon; Jorge Cortes; Jerry P Radich; Andreas Hochhaus; Timothy P Hughes
Journal: Leukemia Date: 2019-06-17 Impact factor: 11.528

2. Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia.

Authors: Shady Adnan Awad; Matti Kankainen; Teija Ojala; Perttu Koskenvesa; Samuli Eldfors; Bishwa Ghimire; Ashwini Kumar; Soili Kytölä; Mahmoud M Kamel; Caroline A Heckman; Kimmo Porkka; Satu Mustjoki
Journal: Blood Adv Date: 2020-02-11

Review 3. Chronic Myelogenous Leukemia in Childhood.

Authors: Stephanie M Smith; Nobuko Hijiya; Kathleen M Sakamoto
Journal: Curr Oncol Rep Date: 2021-03-14 Impact factor: 5.075

4. Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia.

Authors: Yotaro Ochi; Kenichi Yoshida; Ying-Jung Huang; Ming-Chung Kuo; Yasuhito Nannya; Ko Sasaki; Kinuko Mitani; Noriko Hosoya; Nobuhiro Hiramoto; Takayuki Ishikawa; Susan Branford; Naranie Shanmuganathan; Kazuma Ohyashiki; Naoto Takahashi; Tomoiku Takaku; Shun Tsuchiya; Nobuhiro Kanemura; Nobuhiko Nakamura; Yasunori Ueda; Satoshi Yoshihara; Rabindranath Bera; Yusuke Shiozawa; Lanying Zhao; June Takeda; Yosaku Watatani; Rurika Okuda; Hideki Makishima; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Masashi Sanada; Akifumi Takaori-Kondo; Satoru Miyano; Seishi Ogawa; Lee-Yung Shih
Journal: Nat Commun Date: 2021-05-14 Impact factor: 14.919

5. Genomic landscape of neutrophilic leukemias of ambiguous diagnosis.

Authors: Haijiao Zhang; Beth Wilmot; Daniel Bottomly; Kim-Hien T Dao; Emily Stevens; Christopher A Eide; Vishesh Khanna; Angela Rofelty; Samantha Savage; Anna Reister Schultz; Nicola Long; Libbey White; Amy Carlos; Rachel Henson; Chenwei Lin; Robert Searles; Robert H Collins; Daniel J DeAngelo; Michael W Deininger; Tamara Dunn; Than Hein; Marlise R Luskin; Bruno C Medeiros; Stephen T Oh; Daniel A Pollyea; David P Steensma; Richard M Stone; Brian J Druker; Shannon K McWeeney; Julia E Maxson; Jason R Gotlib; Jeffrey W Tyner
Journal: Blood Date: 2019-07-31 Impact factor: 25.476

Review 6. Bcr-Abl Tyrosine Kinase Inhibitors in the Treatment of Pediatric CML.

Authors: Francesca Carofiglio; Antonio Lopalco; Angela Lopedota; Annalisa Cutrignelli; Orazio Nicolotti; Nunzio Denora; Angela Stefanachi; Francesco Leonetti
Journal: Int J Mol Sci Date: 2020-06-23 Impact factor: 5.923

7. Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second-generation tyrosine kinase inhibitors.

Authors: Georgios Nteliopoulos; Alexandra Bazeos; Simone Claudiani; Gareth Gerrard; Edward Curry; Richard Szydlo; Mary Alikian; Hui En Foong; Zacharoula Nikolakopoulou; Sandra Loaiza; Jamshid S Khorashad; Dragana Milojkovic; Danilo Perrotti; Robert Peter Gale; Letizia Foroni; Jane F Apperley
Journal: Haematologica Date: 2019-05-09 Impact factor: 9.941